Radiomics-based prediction of HCC response to atezolizumab/bevacizumab
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
October-2025
|
| In: |
Oncology letters
Year: 2025, Volume: 30, Issue: 4, Pages: 1-12 |
| ISSN: | 1792-1082 |
| DOI: | 10.3892/ol.2025.15229 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3892/ol.2025.15229 Verlag, kostenfrei, Volltext: https://www.spandidos-publications.com/ol |
| Author Notes: | Isaac Rodriguez, Abhinay Vellala, Timo Itzel, Jimmy Daza, Michael Vácha, De-Hua Chang, Manuel Debic, Michael T. Dill, Max Seidensticker, Julia Mayerle, Stefan Munker, Stefan O. Schoenberg, Lukas Müller, Peter R. Galle, Arndt Weinmann, Dietmar Tamandl, Matthias Pinter, Bernhard Scheiner, Christel Weiss, Maciej Pech, Friedrich Sinner, Verena Keitel, Marino Venerito, Matthias Philip Ebert, Andreas Teufel and Matthias F. Froelich |
| Summary: | Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. |
|---|---|
| Item Description: | Online veröffentlicht: 14. August 2025 Gesehen am 18.11.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1792-1082 |
| DOI: | 10.3892/ol.2025.15229 |